Thought Leadership

DFID launches PATHS II in Nigeria

1 Mins read
Thought Leadership

DFID launches PATHS II in Nigeria

1 Mins read

The UK Department for International Development has just launched the second phase of the Partnerships for Transforming Health Systems in Nigeria. The project has been running for the last six years and has been credited with supporting some of the achievements of NAFDAC, the drug control agency and supporting the introduction of better health information management systems in Kaduna State.

The project is based in five states- Enugu, Ekiti, Jigawa, Kaduna, Kano and some support at Federal level

Unfortunately, the communications haven’t been that great- a website has only just been set up and is still under construction

The first phase, PATHS I delivered by a consortium led by HLSP ended in 2007. The second phase has just been launched under new leadership

Hopefully, the new website will help in keeping people abreast of the programme and what it seeks to achieve, and help Nigerians hold their governments and donors to account…

http://www.nigeriahealthwatch.com/

Never doubt that a small group of thoughtful committed people can change the world; indeed it is the only thing that ever has…Margaret Mead

Related posts
Thought Leadership

Exciting start to CPHIA 2023- Breaking Barriers and Repositioning Africa in the Global Health Architecture

5 Mins read
The International Conference on Public Health in Africa (CPHIA) 2023 kicked off in Lusaka, Zambia, on 27th November 2023 with a resounding commitment to breaking…
Thought Leadership

Sustaining the Diaspora Brain Gain through Policies and Private Sector Collaboration

6 Mins read
Nigeria, like many other countries, has been experiencing a health worker migration crisis which is posing a challenge to achieving universal health…
Thought Leadership

Are we there yet? Leveraging the Private Sector for Lassa Vaccine R&D

6 Mins read
The search for an effective vaccine against Lassa fever has gained momentum in recent years. Currently, early supportive care and the anti-viral…

1 Comment

Leave a Reply

Your email address will not be published. Required fields are marked *